ストックスクリーナーアプリを入手
3.245
12.98%
-0.485
前日終値:
$3.73
開ける：
$3.76
24時間の取引高:
1.89M
Relative Volume:
1.56
時価総額：
$216.16M
収益：
$488.00K
当期純損益:
$-41.44M
株価収益率:
-3.4892
EPS:
-0.93
ネットキャッシュフロー:
$-31.47M
1週間 パフォーマンス:
-14.13%
1か月 パフォーマンス:
+3.05%
6か月 パフォーマンス:
-5.91%
1年 パフォーマンス:
+41.13%
1日の値動き範囲:
$3.23
$3.80
1週間の範囲:
$3.23
$4.52
52週間の値動き範囲:
$2.01
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
名前
Cardiff Oncology Inc
セクター
電話
858-952-7570
住所
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
CRDF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
3.2493 | 264.11M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.74 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.91 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.27 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.17 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.45 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-08 | 開始されました | Ladenburg Thalmann | Buy |
| 2025-06-24 | 開始されました | Jefferies | Hold |
| 2024-09-06 | 開始されました | Craig Hallum | Buy |
| 2022-01-05 | 開始されました | William Blair | Outperform |
| 2021-12-08 | 開始されました | Robert W. Baird | Outperform |
| 2021-08-09 | 再開されました | Maxim Group | Buy |
| 2020-10-22 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-08 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Cardiff Oncology Inc (CRDF) 最新ニュース
How Cardiff Oncology Inc. stock performs during market volatilityOversold Stock Bounce Playbook Generator - Newser
Is Cardiff Oncology Inc. stock a growth or value playFree Growth Based Stock Signal Screener - Newser
Is Cardiff Oncology Inc. Stock Overbought or Oversold RSI Indicator AnalysisReal Trader Watchlist with Entry Targets - Newser
Pancreatic Ductal Adenocarcinoma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix - Barchart.com
What catalysts could drive Cardiff Oncology Inc. stock higher in 2025Achieve rapid financial growth with expert picks - jammulinksnews.com
How volatile is Cardiff Oncology Inc. stock compared to the marketGet alerts on the hottest market movers - jammulinksnews.com
How strong is Cardiff Oncology Inc. company’s balance sheetUnlock superior stock analysis tools - jammulinksnews.com
Why is Cardiff Oncology Inc. stock attracting strong analyst attentionAchieve consistent profits with proven methods - jammulinksnews.com
What is the risk reward ratio of investing in Cardiff Oncology Inc. stockBuild a portfolio that outperforms the market - jammulinksnews.com
Should I hold or sell Cardiff Oncology Inc. stock in 2025Build wealth faster with high-performing stocks - jammulinksnews.com
When is Cardiff Oncology Inc. stock expected to show significant growthRealize exceptional returns through smart trading - jammulinksnews.com
New Product Launches: Will They Boost Cardiff Oncology Inc. Stock in 2025Free Investment Portfolio Suggestions - Newser
How Interest Rate Changes Impact Cardiff Oncology Inc. Stock PerformanceFree Join Group - Newser
Cardiff Oncology Inc. Company’s Quarterly Earnings Growth: What the Numbers SayProfit Focused Trade Alerts - Newser
Is Cardiff Oncology Inc. a good long term investmentHigh-octane investment gains - PrintWeekIndia
Published on: 2025-07-25 15:19:32 - PrintWeekIndia
What analysts say about Cardiff Oncology Inc. stockExplosive capital appreciation - Autocar Professional
Cardiff Oncology Inc. Stock Analysis and ForecastExplosive trading opportunities - Autocar Professional
What drives Cardiff Oncology Inc. stock priceFast-track wealth growth - jammulinksnews.com
What makes Cardiff Oncology Inc. stock price move sharplyFree Day Trading Recommendations - Newser
Cardiff Oncology Inc (CRDF) 財務データ
収益
当期純利益
現金流量
EPS
Cardiff Oncology Inc (CRDF) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Levine James E. | Chief Financial Officer |
Dec 18 '24 |
Buy |
5.00 |
2,400 |
12,000 |
67,716 |
| Levine James E. | Chief Financial Officer |
Dec 16 '24 |
Buy |
3.83 |
2,564 |
9,820 |
62,564 |
| TANNENBAUM RENEE P | Director |
Dec 12 '24 |
Buy |
3.42 |
10,000 |
34,224 |
20,000 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
350,115 |
910,299 |
1,047,876 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
11,500 |
29,900 |
1,059,376 |
8.64%
2.63%
大文字化:
|
ボリューム (24 時間):